ArticleFrontiers in oncology2021

Overexpression of PD-L1 is an Independent Predictor for Recurrence in HCC Patients Who Receive Sorafenib Treatment After Surgical Resection.

Yifei Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.